A Randomized, Open-label, Single Oral Dose, 2-way Crossover Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Atorvastatin/fenofibrate (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Acronyms CKD-337 BE
- Sponsors Chong Kun Dang
- 05 Jul 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Feb 2016 New trial record